Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Venkata Lokesh Battula
immunotherapy and AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Inhye Ahn
CLL
Elliot Stieglitz
CMML
Anushree Vichare
Equity in Access
Kura Oncology
MLL leukemia, AML
Qingyu Luo
BPDCN
John DiPersio
trispecific antibody for AML and MDS
Kimberly Stegmaier
childhood blood cancers
Ravindra Majeti
preleukemia, AML
Pietro Genovese
transplant and AML
Daisuke Nakada
preleukemia, leukemia
Christopher Flowers
clinical trial access
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Christine Zhang
AML
Lori Muffly
Equity in Access
Daniel Herranz
T-ALL
Nicoletta Cieri
AML and transplantation
Carl Allen
pediatric blood cancers
Jaehyuk Choi
T-cell lymphoma
Noemí Puig Morón
Myeloma
Neha Mehta-Shah
T-cell lymphoma
Grzegorz Nowakowski
Clinical trial access
Nirav Shah
CAR-T for lymphoma
Julia Maxson
AML
Gianpietro Dotti
CAR T and AML
Sriram Sundaravel
AML stem cells
Jenny Wang
AML
Michael Savona
MDS and leukemia
Liling Wan
AML
Xu Ji
Equity in Access
Alexey Danilov
lymphoma
Ryan Wilcox
T-cell lymphoma
Sham Mailankody
Myeloma immunotherapy clinical trials
Jonas Jutzi
myeloproliferative neoplasms
Maximilian Stahl
AML immunotherapy
Britta Will
Leukemia and pre-leukemia
Jolanta Grembecka
leukemia therapeutics
Eirini Papapetrou
blood cancer stem cells
Rgenta Therapeutics
RNA-targeting, blood cancer
Paolo Caimi
CAR-T clinical trial for CLL
Margaret Shipp
lymphoma biology
Piers Patten
COVID-19
Matthew Frank
Lymphoma CART therapy
Rachel Mersfelder
AMKL
Ana Vujovic
AML
Arash Alizadeh
blood cancer biology and diagnosis
Marco Ruella
Immunotherapy for T-cell lymphoma
Tanya Siddiqi
clinical trial access
Sahand Hormoz
MPN
Mark Murakami
follicular lymphoma
Stephen Gottschalk
pediatric leukemia and CAR-T
Alex Kentsis
pediatric leukemias
ImCheck Therapeutics
immunotherapy, AML
Sigurður Kristinsson
Smoldering myeloma
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Eugenio Morelli
Myeloma
Jonathan Licht
DNA biology, myeloma
Anthony Letai
improving CAR-T
Christopher Booth
BPDCN
Takeshi Sugio
T-cell lymphoma
Sam Butterworth
CMML
Brian Walker
smoldering myeloma, MGUS
Randall Davis
CLL
Michael Green
lymphoma biology
Affimed
immunotherapy, HL, PTCL
Alfred Garfall
myeloma immunotherapy
Carma Bylund
Equity in Access
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Jing Fu
myeloma
Jean Koff
Disparities in DLBCL
Oreofe Odejide
Equity in Access
Yibin Yang
Lymphoma
Qing Yi
Novel CAR-T
Michael Keller
COVID-19, immunotherapy
Suman Paul
T cell cancers and immunotherapy
Andrew Lane
BPDCN
Paul Beavis
immunotherapy in myeloma
Shannon Maude
Immunotherapy for ALL
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Mendel Goldfinger
MDS/AML trials for the elderly
Catriona Jamieson
cancer stem cell biology
Kerry Rogers
CLL
Caron Jacobson
lymphoma and immunotherapy
Frederike Kramer
MPNs
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jayna Mistry
aging and leukemias
Catherine Diefenbach
DLBCL immunology
H. Irene Su
Equity in Access
Jeetayu Biswas
splicing in myeloid diseases
Solu Therapeutics
immunotherapy, CMML
Michael Wang
Mantle Cell Lymphoma
BioInvent International
immunotherapy, indolent NHL, CTCL
Sisi Chen
leukemia
Craig Jordan
AML
Bing Carter
p53 mutant AML
Siegfried Janz
Myeloma immunotherapy
Liran Shlush
pre-leukemia
Jeffrey Magee
pediatric AML
Tomasz Skorski
myeloproliferative neoplasms, AML
Soheil Meshinchi
pediatric AML
Robert Orlowski
(Smoldering) Multiple Myeloma
Robert Soiffer
transplantation
Pooja Khandelwal
bone marrow transplantation
Peter Croucher
Multiple Myeloma
Richard Lock
T-ALL
Saar Gill
AML immunotherapy
Martin Dreyling
Mantle Cell Lymphoma
Yan Liu
MDS
Michaela Reagan
Multiple Myeloma
Simona Colla
Myeloma biology
Jonathon Cohen
lymphoma clinical trial access in Georgia
Areej El-Jawahri
transplant survivorship
Daniel Starczynowski
MDS and AML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Adam Olszewski
Follicular and marginal zone lymphoma
Eric Padron
CMML
Thomas LeBlanc
palliative care
Nicola Vannini
Aging and CAR-T success
Megan McNerney
AML/MDS
Alieen Rowan
Adult T cell leukemia/lymphoma
Yoke Seng Lee
AML
Nataly Cruz-Rodriguez
T-ALL and metabolism
George Vassiliou
Leukemia Prevention
Courtney Jones
AML metabolism
Manyi Wei
acute megakaryoblastic leukemia
Mark Dawson
B-ALL and CAR-T resistance
Anouchka Laurent
T-cell lymphoma
Christian Steidl
B-cell lymphomas
Paolo Strati
Non-Hodgkin Lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
William Matsui
Myeloma
Leandro Cerchietti
DLBCL
Michael Kharas
leukemia
Nizar Bahlis
Myeloma immunotherapy
Catherine Smith
leukemia
Lindsey Montefiori
pediatric leukemia
George Daley
"off-the-shelf" CAR-T and CAR-NK
Eric Pietras
AML
Luca Busino
DLBCL
Tak Mak
Immunotherapy
Raymond Mailhot
Equity in Access
Justine Kahn
pediatric leukemia and lymphoma
Ari Melnick
epigenetics and lymphoma
Matteo Bellone
Smoldering multiple myeloma
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Ricky Johnstone
lymphoma and myeloma
Fenghuang Zhan
Myeloma and bone disease
James Rubenstein
Lymphoma of the Central Nervous System
Urvi Shah
Diet and myeloma
Siddhartha Jaiswal
preleukemia
Jun Qi
Myeloma
Caner Saygin
T-ALL
Bruno Paiva
smoldering myeloma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Bailee Kain
AML and African ancestry
Alison Moskowitz
lymphoma therapeutics
Taishi Yonezawa
AML
Tycel Phillips
Mantle Cell Lymphoma
Cailin Collins
Leukemia and pre-leukemia
Kirk Schultz
pediatric transplantation
Catherine Bollard
pediatric blood cancers and immunotherapy
Brian Dalton
DNA mutations and myeloid cancers
Lucy Godley
preleukemia
Daniel Thomas
Myelofibrosis
Enterome
vaccine, FL, MZL
Ravi Bhatia
transplantation
Susan Schwab
cancer immunology
Timothy Graubert
AML and MDS biology
Enrico Tiacci
Hairy cell leukemia
Madhav Dhodapkar
multiple myeloma immunotherapy
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Tyler Parsons
MPN and AML
Bingyi Chen
AML immunotherapy
Joachim Yahalom
Lymphoma
Alec Zhang
myeloma, immunotherapy
John Crispino
myelofibrosis, pediatric leukemia and Downs
Yiman Liu
Epigenetics and leukemia
Helen Parsons
Equity in Access
Stephen Oh
myeloproliferative neoplasms
Jennifer Woyach
CLL trials
Marina Konopleva
MDS/AML metabolism
Philippe Armand
follicular lymphoma
Adi Nagler
Bronchiolitis obliterans after transplant
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Yubin Zhou
peripheral T cell lymphoma
Meng Li
Equity in Access
Julia Paczkowska
immunobiology of Hodgkin's disease
Mala Shanmugam
myeloma
Hao Jiang
DNA biology and leukemia
Huda Salman
CMML
Kathleen Sakamoto
pediatric AML
Steven Park
follicular lymphoma
Logan Spector
childhood leukemia epidimiology
Gareth Morgan
smoldering myeloma, MGUS
Jennifer Trowbridge
aging and leukemia
Ann-Kathrin Eisfeld
Racial diversity in AML
Frederick Locke
lymphoma and immunotherapy
Ruben Carrasco
Myeloma
Teresa Palomero
Peripheral T-cell Lymphoma
Jing Yang
Myeloma
Suzanne Lentzsch
Myeloma
Steven Horwitz
T-cell lymphomas
Lawrence Boise
CART and myeloma
Christian Marinaccio
MLL leukemias
Stacie Dusetzina
Equity in Access
Nitin Jain
CLL
Srividya Swaminathan
pediatric, immunotherapy
Rizwan Romee
Immunotherapy
John Leonard
lymphoma research
Adam de Smith
pediatric ALL and Down Syndrome
Gaurav Goyal
Erdheim-Chester Disease
Roland Walter
Antibody-based AML therapies
Kasey Leger
pediatric blood cancers
Daniel Pollyea
AML
Roberta Zappasodi
lymphoma, immunotherapy
Ronald Levy
immunotherapies, COVID-19
Lakshmi Nayak
brain tumors in lymphoma
Faron Pharmaceuticals
immunotherapy, MDS
Keisuke Ito
blood cancer stem cells and MDS metabolism
Reina Takeda
AML
Jessica Stewart
Epstein-barr virus and lymphomas
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Omar Abdel-Wahab
Hairy cell leukemia
Wendy Béguelin
follicular lymphoma
Hong Wen
AML
Jalpa Doshi
Equity in Access
Amin Sobh
Myeloma biology
Jianguo Tao
Mantle Cell Lymphoma
Koichi Takahashi
AML/MDS
Amit Verma
AML/MDS
Jianhua Yu
myeloma immunotherapy
Dimericon Therapeutics
dimericons, blood cancer
Sergei Doulatov
Leukemias
Grant Challen
preleukemia, leukemia
Jake Shortt
precision therapy for aggressive lymphomas
Daniel Lucas
bone marrow and leukemia biology
Marc Seifert
Hairy cell leukemia
Thomas Koehnke
leukemia
Caroline Arber
myeloma CAR-T
Thomas Kipps
Hairy Cell Leukemia
Armin Rashidi
gut bacteria and transplant success
Carl June
CAR T immunotherapy
Stephen Nimer
myeloid cancer biology
Coleman Lindsley
AML/MDS
Rong Lu
preleukemia, leukemia
Fahmin Basher
transplant and GvHD
Mark Hamilton
DLBCL and CAR-T
Dane Vassiliadis
blood cancer biology
Dan Landau
cancer evolution biology
Trent Hall
MDS
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Christopher Porter
Leukemia, lymphoma
Jeremy Baeten
AML
Nicolas Nassar
pediatric leukemia
Courtney DiNardo
clinical trials, AML
Rajni Kumari
AML
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Sheng Li
Aging and AML
Markus Muschen
leukemia and lymphoma biology
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Peter Klein
MDS
Steven Treon
Lymphomas and Waldenstrom's
Wendy Stock
T-cell ALL
Shazia Nakhoda
Equity in Access
Jaroslaw Maciejewski
bone marrow failure
Sarah Tasian
pediatric leukemias
F. Lennie Wong
Equity in Access
Lev Kats
myeloma and epigenetics
Ramon Massoni-Badosa
CLL and Richter's Syndrome